On August 29, 2023 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") reported that members of its senior management team are scheduled to participate in upcoming investor conferences, detailed below (Press release, Innate Pharma, AUG 29, 2023, View Source [SID1234634767]). In addition, the Company will hold a conference call on Thursday, September 14, 2023, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 18th Annual BioPharma Conference
Event Date: September 6 – 7, Boston

H.C. Wainwright 25th Annual Global Investment Conference
Event Date: September 11 – 13, New-York

Morgan Stanley 21st Annual Global Healthcare Conference
Event Date: September 11 – 13, New-York

First Half 2023 Financial Results and Business Update
Event Date: September 14 – Conference call and Webcast